PLX-PAD
- Generic Name
- PLX-PAD
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- DPX6XLD4X1
- Associated Conditions
- -
- Associated Therapies
- -
Expanded Access Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
- Conditions
- First Posted Date
- 2019-03-22
- Last Posted Date
- 2020-07-28
- Lead Sponsor
- Pluristem Ltd.
- Registration Number
- NCT03886506
- Locations
- ๐บ๐ธ
OBL-NJ Endovascular & Amputation Prevention, LLC,1429 Broad St., Clifton, NJ, Clifton, New Jersey, United States
๐บ๐ธHoly Name Medical Center,718 Teaneck Road, Teaneck, New Jersey, United States
Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)
- First Posted Date
- 2018-03-02
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Pluristem Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT03451916
- Locations
- ๐ง๐ฌ
MHAT "Serdika" Department of Orthopedy and Traumatology, Sofia, Bulgaria
๐ง๐ฌMilitary Medical Academy, Sofia, Bulgaria
๐ง๐ฌSpecialized Hospital for Active Treatment in Orthopedy, Sofia, Bulgaria
Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)
- First Posted Date
- 2013-02-21
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- United Therapeutics
- Target Recruit Count
- 6
- Registration Number
- NCT01795950
- Locations
- ๐ฆ๐บ
The Prince Charles Hospital, Brisbane, Queensland, Australia
๐ฆ๐บThe Alfred Hospital, Melbourne, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2024. All Rights Reserved by MedPath